| | | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
|---|
| Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
| | | FI | PI | | Fucithalmic | 5 g | 4.59 | 9.35 | 10% | | Tropfgel: Acidum Fusidicum 10 mg/g | Recordati AG | A / SL | FB | | G |  |
|
| | | | | | Azyter | 6 x 0.25 g | PA | PA | k.A. | | Augentropfen: Azithromycinum Dihydricum 3.75 mg | THEA Pharma S.A. | A | FB | | G | |
|
| | | FI | | | Aprokam | Durchstechflasche(n) | PA | PA | k.A. | | Trockensubstanz: Cefuroximum 50 mg | THEA Pharma S.A. | A | FB | | G | |
| | | FI | | | Aprokam | 10 Durchstechflasche(n) | PA | PA | k.A. | | Trockensubstanz: Cefuroximum 50 mg | THEA Pharma S.A. | A | FB | | G | |
| | | FI | | | Aprokam | 10 | PA | PA | k.A. | | Trockensubstanz: Cefuroximum 50 mg | THEA Pharma S.A. | A | FB | | G | |
|
| | | FI | PI | | AciVision 30 mg/g | 4.5 g | 9.69 | 19.30 | 10% | | Augensalbe: Aciclovirum 30 mg | OmniVision AG | A / SL | FB | | G | |
| | | FI | PI | | Virupos 30 mg/g | 4.5 g | 10.91 | 20.70 | 10% | | Augensalbe: Aciclovirum 30 mg | URSAPHARM Schweiz
GmbH | A / SL | FB | | G | |
| | | FI | | | Xorox 30 mg/g | 4.5 g | PA | PA | k.A. | | Augensalbe: Aciclovirum 30 mg | AGEPHA PHARMA s.r.o.,
Bratislava,
Zweigniederlassung Zug | A | FB | | G | |
|
| | | FI | PI | | Posiformin 2 % | 5 g | 4.66 | 9.45 | k.A. | | Augensalbe: Bibrocatholum 20 mg | URSAPHARM Schweiz
GmbH | B | FB | | G | |
|
| | | FI | PI | | Ciloxan | Tube(n) à 3.5 g | 4.84 | 9.65 | 10% | | Augensalbe: Ciprofloxacinum 3 mg | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| | | FI | PI | | Ciloxan | 5 ml | 4.84 | 9.65 | 10% | | Augentropfen: Ciprofloxacinum 3 mg/ml | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
|
| | | FI | PI | | Dexafree UD 0,1% | 20 Einzeldosen | 4.75 | 9.55 | 10% | | Augentropfen: Dexamethasoni Natrii Phosphas 1.093 mg/ml | THEA Pharma S.A. | A / SL | FB | | G | |
| | | FI | PI | | Maxidex | 5 ml | 3.45 | 8.05 | 10% | | Augentropfen: Dexamethasonum 1 mg | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| | | FI | PI | | Spersadex mono 0.1% | 5 ml | 4.64 | 9.45 | 10% | | Augentropfen: Dexamethasoni Natrii Phosphas 1 mg/ml | OmniVision AG | A / SL | FB | | G | |
| L | | FI | | | Ozurdex | Stück | 1091.66 | 1258.80 | 10% | | intravitreales Implantat in Applikator: Dexamethasonum | AbbVie AG | A / SL | FB | | G | |
|
| | | FI | PI | | FML Liquifilm | 5 ml | 3.09 | 7.65 | 10% | | Augentropfen: Fluorometholonum 1 mg/ml | AbbVie AG | A / SL | FB | | G | |
|
| | | FI | PI | | Dicloabak 0,1% collyre | 10 ml | 10.39 | 20.15 | 10% | | Augentropfen: Diclofenacum Natricum 1 mg/ml | THEA Pharma S.A. | B / SL / SG | FB | | G | |
| | | FI | | | Voltaren Ophtha | 5 ml | PA | 26.70 | k.A. | | Augentropfen: Diclofenacum Natricum 1 mg | Novartis Pharma
Schweiz AG | B | FB | | G | |
|
| | | FI | PI | | Yellox | 5 ml | 8.97 | 18.50 | 10% | | Augentropfen: Bromfenacum | Bausch & Lomb Swiss AG | ● B / SL | FB | | G | |
|
| | | FI | PI | | Maxitrol | 5 ml | 3.89 | 8.55 | 10% | | | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| | | FI | PI | | Tobradex | 5 ml | 5.16 | 14.10 | 10% | | | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| | | FI | PI | | Maxitrol | 3.5 g | 3.55 | 8.20 | 10% | | Augensalbe: 3 Wirkstoffe | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| | | FI | PI | | Tobradex | 3.5 g | 4.73 | 9.55 | 10% | | Augensalbe: 2 Wirkstoffe | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| | | FI | PI | | Dexagenta-POS | 5 ml | 2.91 | 7.45 | 10% | | Augentropfen: 2 Wirkstoffe | URSAPHARM Schweiz
GmbH | ● A / SL | FB | | G | |
| | | FI | PI | | Spersadex comp. | 5 ml | 5.00 | 13.95 | 10% | | Augentropfen: 2 Wirkstoffe | THEA Pharma S.A. | A / SL | FB | | G | |
| | | FI | PI | | Ducressa 1 mg / mL & 5 mg / mL | 5 ml | PA | PA | k.A. | | collyre en solution: 2 Wirkstoffe | Santen SA | A | FB | | G | |
| | | FI | PI | | Frakidex | 5 ml | 1.57 | 5.90 | k.A. | | | Bausch & Lomb Swiss AG | A | FB | | G | |
|
| | | FI | PI | | FML-Neo Liquifilm | 5 ml | 4.07 | 8.75 | 10% | | Augentropfen: 2 Wirkstoffe | AbbVie AG | A / SL | FB | | G | |
|
| | | FI | PI | | Iopidine 0,5 % | 5 ml | 14.42 | 28.85 | 10% | | Augentropfen: Apraclonidinum 5 mg/ml | Essential Pharma
Switzerland GmbH | B / SL | FB | | G | |
| | | FI | PI | | Iopidine 1% | Einzeldosen à 2 ml | 9.61 | 19.25 | 10% | | Augentropfen (Monodosen): Apraclonidinum 10 mg/ml | Essential Pharma
Switzerland GmbH | B / SL | FB | | G | |
|
| | | FI | PI | | Alphagan | 5 ml | 8.67 | 18.15 | 10% | | Augentropfen: Brimonidini Tartras 2 mg/ml | AbbVie AG | B / SL / SO | FB | | G | |
| | | FI | PI | | Alphagan | 3 x 5 ml | 22.15 | 41.85 | 10% | | Augentropfen: Brimonidini Tartras 2 mg/ml | AbbVie AG | B / SL / SO | FB | | G | |
| | | FI | PI | | Brimonidin-Mepha 2mg/ml | 5 ml | 8.52 | 18.00 | 10% | | Augentropfen: Brimonidini Tartras 2 mg/ml | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Brimonidin-Mepha 2mg/ml | 3 x 5 ml | 19.94 | 39.30 | 10% | | Augentropfen: Brimonidini Tartras 2 mg/ml | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Brimo-Vision 2 mg/ml | 60 x 0.35 ml | 8.52 | 18.00 | 10% | | Augentropfen (Einzeldosen): Brimonidini Tartras 2 mg/ml | OmniVision AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Brimo-Vision 2 mg/ml | 180 x 0.35 ml | 19.94 | 39.30 | 10% | | Augentropfen (Einzeldosen): Brimonidini Tartras 2 mg/ml | OmniVision AG | B / SL / SG | FB | | G | |
| | | FI | | | Brimonidine Labatec 2
mg/ml | 5 ml | PA | PA | k.A. | | collyre en solution: Brimonidini Tartras 2 mg/ml | Labatec Pharma SA | B | FB | | G | |
|
| | | FI | | | Miostat | 12 1 Ampulle(n) à 1.5 ml | PA | PA | k.A. | | Injektionslösung: Carbacholum | Alcon Switzerland SA | B | FB | | G | |
|
| | | FI | PI | | Miochol E | 2 ml | PA | PA | k.A. | | Injektionslösung: Acetylcholini Chloridum 20 mg | Bausch & Lomb Swiss AG | B | FB | | G | |
|
| | | FI | PI | | Diamox i.v. | 500 mg | 12.36 | 26.50 | 10% | | Injektionspräparat: Acetazolamidum 500 mg | OM Pharma Suisse SA | B / SL | FB | | G | |
| | | FI | PI | | Diamox - T | 25 Tablette(n) | 6.05 | 15.15 | 10% | | Tabletten: Acetazolamidum 250 mg | OM Pharma Suisse SA | B / SL | FB | | G | |
| | | FI | PI | | Glaupax - T | 40 Tablette(n) | 7.67 | 17.00 | 10% | | Tabletten: Acetazolamidum 250 mg | OmniVision AG | B / SL | FB | | G | |
| | | FI | PI | | Glaupax - T | 100 Tablette(n) | 19.16 | 38.40 | 10% | | Tabletten: Acetazolamidum 250 mg | OmniVision AG | B / SL | FB | | G | |
| | | FI | PI | | Diamox Sustets | 30 Kapsel(n) | 25.89 | 46.85 | k.A. | | Kapseln: Acetazolamidum 500 mg | Corden Pharma
Fribourg SA | B | FB | | G | |
|
| | | FI | PI | | Trusopt | 5 ml | 10.33 | 20.05 | 10% | | | Santen SA | B / SL / SO | FB | | G | |
| | | FI | PI | | Trusopt | 3 x 5 ml | 24.15 | 44.10 | 10% | | | Santen SA | B / SL / SO | FB | | G | |
| | | FI | PI | | Dorzo-Vision 2 % | 5 ml | 9.85 | 19.50 | 10% | | Augentropfen: Dorzolamidum 20 mg/ml | OmniVision AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Dorzo-Vision 2 % | 3 x 5 ml | 21.50 | 41.10 | 10% | | Augentropfen: Dorzolamidum 20 mg/ml | OmniVision AG | B / SL / SG | FB | | G | |
|
| | | FI | PI | | Azopt | 5 ml | 9.96 | 19.65 | 10% | | | Novartis Pharma
Schweiz AG | B / SL | FB | | G | |
| | | FI | PI | | Azopt | 3 x 5 ml | 25.41 | 45.55 | 10% | | | Novartis Pharma
Schweiz AG | B / SL | FB | | G | |
|
| | | FI | PI | | Simbrinza, Brinzolamid
10mg/ml | 5 ml | 16.63 | 35.50 | 10% | | Brimonidintartrat: 2 Wirkstoffe | Novartis Pharma
Schweiz AG | B / SL | FB | | G | |
| | | FI | PI | | Simbrinza, Brinzolamid
10mg/ml | 3 x 5 ml | 47.39 | 70.80 | 10% | | Brimonidintartrat: 2 Wirkstoffe | Novartis Pharma
Schweiz AG | B / SL | FB | | G | |
|
| | | FI | PI | | Betoptic-S | 5 ml | 5.05 | 14.00 | 10% | | Augentropfen: Betaxololum 2.5 mg/ml | Medius AG | B / SL | FB | | G | |
| | | FI | PI | | Betoptic-S | 3 x 5 ml | 12.89 | 27.10 | 10% | | Augentropfen: Betaxololum 2.5 mg/ml | Medius AG | B / SL | FB | | G | |
| | | FI | PI | | Betoptic-S Single Dose | 60 Stück | PA | 60.00 | k.A. | | | Medius AG | B | FB | | G | |
|
| | | FI | PI | | Arteoptic LA 2 % | 3 ml | 5.05 | 14.00 | 10% | | Augentropfen: Carteololi Hydrochloridum 20 mg/ml | Bausch & Lomb Swiss AG | B / SL | FB | | G | |
| | | FI | PI | | Arteoptic LA 2% UD | 30 1 Einzeldosen à 0.2 ml | 7.45 | 16.75 | 10% | | Augentropfen: Carteololi Hydrochloridum 20 mg/ml | Bausch & Lomb Swiss AG | B / SL | FB | | G | |
| | | FI | PI | | Arteoptic LA 2 % | 3 x 3 ml | 12.93 | 27.15 | 10% | | Augentropfen: Carteololi Hydrochloridum 20 mg/ml | Bausch & Lomb Swiss AG | B / SL | FB | | G | |
| | | FI | PI | | Arteoptic LA 1% UD | 30 1 Einzeldosen à 0.2 ml | 10.28 | 20.00 | k.A. | | Augentropfen: Carteololi Hydrochloridum 10 mg/ml | Bausch & Lomb Swiss AG | B | FB | | G | |
| | | FI | PI | | Arteoptic 0,5 %,
Augentropfen | 5 ml | 6.60 | 15.80 | 10% | | Carteololi Hydrochloridum 20 mg | Bausch & Lomb Swiss AG | B / SL | FB | | G | |
| | | FI | PI | | Arteoptic 0,5 %,
Augentropfen | 3 x 5 ml | 16.84 | 35.75 | k.A. | | Carteololi Hydrochloridum 20 mg | Bausch & Lomb Swiss AG | B | FB | | G | |
|
| | | FI | PI | | Lumigan, 0.1 mg/ml | 3 ml | 14.66 | 29.15 | 10% | | Augentropfen: Bimatoprostum | AbbVie AG | B / SL | FB | | G | |
| | | FI | PI | | Lumigan, 0.1 mg/ml | 3 x 3 ml | 41.16 | 63.65 | 10% | | Augentropfen: Bimatoprostum | AbbVie AG | B / SL | FB | | G | |
| | | FI | PI | | Lumigan 0,3 mg/ml Unit
Dose | 30 x 0.4 ml | 17.82 | 36.85 | 10% | | Augentropfen: Bimatoprostum | AbbVie AG | B / SL | FB | | G | |
| | | FI | PI | | Lumigan 0,3 mg/ml Unit
Dose | 90 x 0.4 ml | 50.80 | 74.70 | 10% | | Augentropfen: Bimatoprostum | AbbVie AG | B / SL | FB | | G | |
| | | FI | PI | | Bimatoprost Labatec 0.3
mg/ml | 3 ml | PA | PA | k.A. | | collyre en solution: Bimatoprostum | Labatec Pharma SA | B | FB | | G | |
|
| | | FI | PI | | Atropine 0,5 % SDU Faure | 4 x 5 Einzeldosen | PA | 31.35 | k.A. | | Augentropfen: Atropini Sulfas 5 mg/ml | THEA Pharma S.A. | B | FB | | G | |
| | | FI | PI | | Atropine 1% SDU Faure | 4 x 5 Einzeldosen | PA | 31.35 | k.A. | | Augentropfen: Atropini Sulfas 10 mg/ml | THEA Pharma S.A. | B | FB | | G | |
| | | FI | PI | | Skiatropin 0 | 4 ml | 2.85 | 6.85 | k.A. | | Augentropfen: Atropini Sulfas 3 mg | Chauvin Novopharma AG | B | FB | | G | |
|
| | | FI | | | Cyclogyl 0,5 % | 10 ml | PA | 25.30 | k.A. | | Augentropfen: Cyclopentolati Hydrochloridum 5 mg/ml | Alcon Switzerland SA | B | FB | | G | |
| | | FI | | | Cyclogyl 1 % | 10 ml | PA | 25.30 | k.A. | | Augentropfen: Cyclopentolati Hydrochloridum 10 mg/ml | Alcon Switzerland SA | ● B | FB | | G | |
|
| | | FI | PI | | Allergo-COMOD | 10 ml | 6.00 | 11.05 | 10% | | Augentropfen: Natrii Cromoglicas 20 mg/ml | URSAPHARM Schweiz
GmbH | D / SL / SG | FB | | G | |
| | | FI | PI | | Opticrom-Allergo | 20 x 0.3 ml | PA | PA | k.A. | | Augentropfen in Ampullen: Natrii Cromoglicas 20 mg/ml | Opella Healthcare
Switzerland AG | D | FB | | G | |
| | | FI | PI | | Opticrom-Allergo | 40 x 0.3 ml | PA | PA | k.A. | | Augentropfen in Ampullen: Natrii Cromoglicas 20 mg/ml | Opella Healthcare
Switzerland AG | D | FB | | G | |
|
| | | FI | PI | | Emadine | 5 ml | 9.23 | 17.05 | 10% | | Augentropfen: Emedastinum | Medius AG | D / SL | FB | | G | |
| | | FI | PI | | Emadine SE | 30 1 Einzeldosen à 0.35 ml | 13.39 | 24.70 | k.A. | | Augentropfen: Emedastinum | Medius AG | D | FB | | G | |
| | | FI | PI | | Helux | 5 ml | PA | PA | k.A. | | Augentropfen: Emedastinum | Future Health Pharma
GmbH | D | FB | | G | |
|
| | | FI | PI | | Allergodil | 6 ml | 6.00 | 15.10 | 10% | | Augentropfen: Azelastini Hydrochloridum | MEDA Pharma GmbH | B / SL | FB | | G | |
| | | FI | PI | | Allergodil saisonal | 4 ml | PA | PA | k.A. | | Augentropfen: Azelastini Hydrochloridum | MEDA Pharma GmbH | D | FB | | G | |
| | | | | | Vividrin 0.5 mg/ml | 6 ml | PA | PA | k.A. | | Augentropfen: Azelastini Hydrochloridum | Bausch & Lomb Swiss AG | B | FB | | G | |
|
| | KFI | FI | PI | | Relestat | 5 ml | 7.75 | 17.10 | 10% | | | AbbVie AG | B / SL | FB | | G | |
|
| | | FI | PI | | Fluorescéine 0,5 % SDU
Faure | 4 x 5 Einzeldosen | PA | 25.15 | k.A. | | Augentropfen: Fluoresceinum Natricum 5 mg/ml | Curatis AG | B | FB | | G | |
| | | FI | PI | | Fluoresceine 10 % Faure | 10 1 Ampulle(n) à 5 ml | PA | PA | k.A. | | Injektionslösung: Fluoresceinum Natricum 500mg / 5ml | Curatis AG | B | FB | | G | |
|
| | | FI | | | Fluoresceine
Oxybuprocaine SDU Faure | 20 Einzeldosen | PA | PA | k.A. | | Augentropfen: 2 Wirkstoffe | OmniVision AG | B | FB | | G | |
|
| L | | FI | | PS | Eylea | Durchstechflasche(n) | 845.90 | 987.50 | 10% | | Lösung zur intravitrealen Injektion in einer Durchstechflasche: Afliberceptum 2mg / 50µl | Bayer (Schweiz) AG | B / SL | FB | | G | |
| L | | FI | | PS | Eylea | | 845.90 | 987.50 | 10% | | Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µl | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | | FI | | PS | Eylea | Spritze(n) | 913.48 | 1063.35 | k.A. | | Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µl | Bayer (Schweiz) AG | B | FB | | G | |
|
| L | | FI | | | Beovu 120mg/1ml | | 863.07 | 1007.20 | 10% | | Injektionslösung in Fertigspritze: Brolucizumabum 120 mg/ml | Novartis Pharma
Schweiz AG | B / SL | FB | | G | |
|
| L | | FI | | | Jetrea | | 3020.36 | 3341.85 | 10% | | Injektionslösung: Ocriplasminum 1.25 mg/ml | mmpharm GmbH | B / SL | FB | | G | |
|
| | | FI | PI | PS | Oxervate | 7 | PA | PA | k.A. | | Augentropfen: Cenegerminum | Dompé International SA | B | FB | | G | |
|
| | | | PI | H | Mucokehl D5 | 5 ml | PA | PA | k.A. | | Augentropfen: Mucor Racemosus e Volumine Cellulae (Lyophil., Steril.) D5 Aquos (Hab 5B) | ebi-pharm ag | D | FB | | G | |
| | | | PI | H | Similasan Allergisch
reagierende Augen | 10 ml | PA | PA | k.A. | | Augentropfen: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | | G | |
| | | | PI | H | Similasan Trockene Augen | 10 ml | PA | PA | k.A. | | Augentropfen: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | | G | |
| | | | PI | | Similasan überanstrengte
Augen N | 20 | PA | PA | k.A. | | Augentropfen: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | | G | |
| | | | PI | H | Oculoheel | 20 x 0.45 ml | PA | PA | k.A. | | Augentropfen Monodosen: 4 Wirkstoffe | ebi-pharm ag | D | FB | | G | |
| | | | PI | | Similasan Allergisch
reagierende Augen N | 20 x 0.4 ml | PA | PA | k.A. | | Augentropfen Monodosen: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | | G | |
| | | | PI | | Similasan Entzündete
Augen N | 20 x 0.4 ml | PA | PA | k.A. | | Augentropfen Monodosen: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | | G | |
| | | | PI | | Similasan Trockene Augen N | 20 x 0.4 ml | PA | PA | k.A. | | Augentropfen Monodosen: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | | G | |
| | | | PI | H | Similasan Entzündete
Augen, Augentropfen 10 ml | 10 ml | PA | PA | k.A. | | Lösung: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | | G | |
| | | | PI | H | Similasan Überanstrengte
Augen, Augentropfen 10 ml | 10 ml | PA | PA | k.A. | | Lösung: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | | G | |
